2016 Revision to the WHO Classification of Acute Myeloid Leukemia.
作者信息
Hong Ming, He Guangsheng
机构信息
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, Jiangsu Province, China.
出版信息
J Transl Int Med. 2017 Jun 30;5(2):69-71. doi: 10.1515/jtim-2016-0041. eCollection 2017 Jun.
Abstract
摘要
相似文献
1
2016 Revision to the WHO Classification of Acute Myeloid Leukemia.《世界卫生组织急性髓系白血病分类（2016年修订版）》
J Transl Int Med. 2017 Jun 30;5(2):69-71. doi: 10.1515/jtim-2016-0041. eCollection 2017 Jun.
2
The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.2016 年版 WHO 急性髓系白血病分类：临床医生须知
Semin Hematol. 2019 Apr;56(2):90-95. doi: 10.1053/j.seminhematol.2018.08.002. Epub 2018 Aug 22.
3
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.2016 年版世界卫生组织淋巴造血和髓系肿瘤及急性白血病分类修订的实际意义。
J Clin Oncol. 2017 Aug 10;35(23):2708-2715. doi: 10.1200/JCO.2017.72.6745. Epub 2017 Jun 27.
4
Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.根据2016年世界卫生组织分类标准对急性红系白血病进行重新评估。
Leuk Res. 2017 Oct;61:39-43. doi: 10.1016/j.leukres.2017.08.011. Epub 2017 Aug 25.
5
An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.对97例先前诊断的初发成年急性红系白血病患者按照2016年世界卫生组织分类修订版进行的分析。
BMC Cancer. 2017 Aug 9;17(1):534. doi: 10.1186/s12885-017-3528-6.
6
Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.采用修订版第四版世界卫生组织标准对急性髓系白血病进行分类：一项回顾性单机构研究，评估了具有 NPM1 和双等位 CEBPA 基因突变的急性髓系白血病新实体。
Hum Pathol. 2019 Aug;90:80-96. doi: 10.1016/j.humpath.2019.04.020. Epub 2019 May 8.
7
Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.2001 - 2013年监测、流行病学和最终结果（SEER）数据库分析：成人非特殊类型急性髓系白血病及伴有复发性基因异常的急性髓系白血病的发病率、生存率和危险因素
Acta Haematol. 2018;139(2):115-127. doi: 10.1159/000486228. Epub 2018 Feb 16.
8
Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition.家族性骨髓增生异常/急性白血病综合征——具有种系易感性的髓系肿瘤
Front Oncol. 2017 Sep 12;7:206. doi: 10.3389/fonc.2017.00206. eCollection 2017.
9
Classification of acute leukemias.急性白血病的分类
Semin Diagn Pathol. 2003 Aug;20(3):142-53. doi: 10.1016/s0740-2570(03)00031-5.
10
[Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].[髓系血液系统恶性肿瘤的诊断：2001年世界卫生组织（WHO）分类的贡献]
Ann Biol Clin (Paris). 2004 Sep-Oct;62(5):513-20.
引用本文的文献
1
Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins.组蛋白去乙酰化酶在伴有融合蛋白的急性髓系白血病中的作用
Front Oncol. 2021 Sep 1;11:741746. doi: 10.3389/fonc.2021.741746. eCollection 2021.
2
A heavy metal baseline score predicts outcome in acute myeloid leukemia.重金属基线评分可预测急性髓系白血病的结局。
Am J Hematol. 2020 Apr;95(4):422-434. doi: 10.1002/ajh.25731. Epub 2020 Mar 4.
3
Identification of a novel long non-coding RNA within RUNX1 intron 5.鉴定 RUNX1 内含子 5 内的一个新型长非编码 RNA。
Hum Genomics. 2019 Jul 31;13(1):33. doi: 10.1186/s40246-019-0219-1.
4
MYC protein expression is an important prognostic factor in acute myeloid leukemia.MYC 蛋白表达是急性髓系白血病的一个重要预后因素。
Leuk Lymphoma. 2019 Jan;60(1):37-48. doi: 10.1080/10428194.2018.1464158. Epub 2018 May 9.
本文引用的文献
1
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.单一癌基因增强子重排导致白血病中 EVI1 和 GATA2 的同时失调。
Cell. 2014 Apr 10;157(2):369-381. doi: 10.1016/j.cell.2014.02.019. Epub 2014 Apr 3.
2
Does BCR/ABL1 positive acute myeloid leukaemia exist?BCR/ABL1 阳性急性髓系白血病是否存在？
Br J Haematol. 2013 May;161(4):541-50. doi: 10.1111/bjh.12301. Epub 2013 Mar 25.
3
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.RUNX1 突变与细胞遗传学正常的急性髓系白血病的年轻和老年患者的不良预后相关，并与独特的基因和 MicroRNA 表达特征相关。
J Clin Oncol. 2012 Sep 1;30(25):3109-18. doi: 10.1200/JCO.2011.40.6652. Epub 2012 Jul 2.
4
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.RUNX1 突变在非复杂性核型的初发性 AML 中频繁发生，并预示不良预后。
Blood. 2011 Feb 24;117(8):2348-57. doi: 10.1182/blood-2009-11-255976. Epub 2010 Dec 9.
5
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.双CEBPA突变而非单CEBPA突变定义了急性髓系白血病的一个亚组，该亚组具有独特的基因表达谱，且与良好预后唯一相关。
Blood. 2009 Mar 26;113(13):3088-91. doi: 10.1182/blood-2008-09-179895. Epub 2009 Jan 26.
Zotero 插件